Eyegate Pharmaceuticals

$4.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+0.94%) Today

-$0.09 (-2.09%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell EYEG and other stocks, options, and ETFs commission-free!

About EYEG

Eyegate Pharmaceuticals, Inc. Common Stock, also called Eyegate Pharmaceuticals, is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye.

CEO

Franz Obermayr

Employees

Headquarters

Waltham, Massachusetts

Founded

1998

Market Cap

30.95M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

13.34K

High Today

$4.31

Low Today

$4.11

Open Price

$4.27

Volume

12.09K

52 Week High

$8.18

52 Week Low

$3.20

EYEG Earnings

-$1.15

-$0.77

-$0.38

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 5, After Hours